21 May 2009
Assessment of a novel prognostic index in prediction of early mortality after liver transplantation
J Raszeja-Wyszomirska, M Wasilewicz, B Szymanik, E Wunsch, K Jarosz, M Wójcicki, P MilkiewiczAnn Transplant 2009; 14(1): 40-40 :: ID: 880342
Abstract
Background: The Model of End Stage Liver Disease (MELD) predicts mortality on the transplant list, however it is not of a much use in predicting post-transplant outcome. Several prognostic models (PM) have been tested in patients with cirrhosis, nevertheless their predictive value in post-transplant setting has not been established. We have recently designed a novel PM based on a Child-Pugh-Turcotte score and creatinine levels (CPT+Crea), which proved to be useful in patients with cirrhosis (Wunsch et al Gastroent Pol 2008). Aim: Retrospective analysis of the prediction of early (1 month) mortality with CPT+Crea and five other PM in patients, who underwent liver transplantation (LTx) in our centre.
Material/Methods: Forty eight consecutive patients (30 males, 18 females, mean age 51 years) were included. Predictive value of CPT+Crea was compared with Child-Pugh-Turcotte score (CPT), CPT in Huo modification (CPTHuo) (Huo et al Liver Transpl 2006), CPT+Na, MELD and MESO. Pearson correlation and ROC curves/area under the curve (AUC) were determined for each index. P values <0.05 were considered significant.
Results: CPT-Crea showed the highest correlation with the risk of death (r=0.368, p=0.01) and MELD and MESO the lowest (r=0.204, p=NS and r=0.254, p=NS respectively). Also ROC analysis showed the best predictive value of CPT-Crea with AUC of 0.748 as compared to 0.689 for MESO and 0.659 for MELD.
Conclusions: A novel index based on Child-Pugh-Turcotte score and creatinine levels is a significantly better predictor of early death after LTx than already used scores. Its usefulness should be validated in a prospective trial and a larger cohort of patients.
Keywords: Liver Transplantation
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860